These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29156596)

  • 1. Microvesicle Involvement in Shiga Toxin-Associated Infection.
    Villysson A; Tontanahal A; Karpman D
    Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29156596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles.
    Ståhl AL; Arvidsson I; Johansson KE; Chromek M; Rebetz J; Loos S; Kristoffersson AC; Békássy ZD; Mörgelin M; Karpman D
    PLoS Pathog; 2015 Feb; 11(2):e1004619. PubMed ID: 25719452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
    Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D
    J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Characterization of Shiga Toxin-Associated Microvesicles.
    Willysson A; Ståhl AL; Karpman D
    Methods Mol Biol; 2021; 2291():207-228. PubMed ID: 33704755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
    Ståhl AL; Sartz L; Nelsson A; Békássy ZD; Karpman D
    PLoS One; 2009 Sep; 4(9):e6990. PubMed ID: 19750223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor.
    Johansson K; Willysson A; Kristoffersson AC; Tontanahal A; Gillet D; Ståhl AL; Karpman D
    Front Cell Infect Microbiol; 2020; 10():212. PubMed ID: 32523894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement in typical hemolytic uremic syndrome.
    Orth D; Würzner R
    Semin Thromb Hemost; 2010 Sep; 36(6):620-4. PubMed ID: 20865638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell-derived arginase release in hemolytic uremic syndrome.
    Friberg N; Arvidsson I; Tontanahal A; Kristoffersson AC; Gram M; Kaplan BS; Karpman D
    J Transl Med; 2024 Jan; 22(1):17. PubMed ID: 38178089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome.
    Orth D; Khan AB; Naim A; Grif K; Brockmeyer J; Karch H; Joannidis M; Clark SJ; Day AJ; Fidanzi S; Stoiber H; Dierich MP; Zimmerhackl LB; Würzner R
    J Immunol; 2009 May; 182(10):6394-400. PubMed ID: 19414792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
    Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children.
    Brigotti M; He X; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Tazzari PL; Ricci F; Patfield SA; Testa S; Paglialonga F; Picicco D; Caprioli A; Scavia G; Morabito S; Ardissino G
    Thromb Haemost; 2020 Jan; 120(1):107-120. PubMed ID: 31858520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of circulating microvesicles containing Shiga toxin type 2 in a rat model of Hemolytic Uremic Syndrome.
    Sacerdoti F; Gomez FD; Jancic C; Lombardo T; Pascuale CA; Moretton MA; Chiappetta DA; Ibarra C; Amaral MM
    Toxicon; 2023 Dec; 236():107349. PubMed ID: 37979924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga Toxin Therapeutics: Beyond Neutralization.
    Hall G; Kurosawa S; Stearns-Kurosawa DJ
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28925976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
    Pirschel W; Mestekemper AN; Wissuwa B; Krieg N; Kröller S; Daniel C; Gunzer F; Tolosano E; Bauer M; Amann K; Heinemann SH; Coldewey SM
    Kidney Int; 2022 Jun; 101(6):1171-1185. PubMed ID: 35031328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells.
    Lee KS; Park JY; Jeong YJ; Lee MS
    J Microbiol; 2023 Aug; 61(8):715-727. PubMed ID: 37665555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
    Karpman D; Ståhl AL; Arvidsson I; Johansson K; Loos S; Tati R; Békássy Z; Kristoffersson AC; Mossberg M; Kahn R
    Adv Exp Med Biol; 2015; 865():19-42. PubMed ID: 26306441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.
    Zoja C; Buelli S; Morigi M
    Pediatr Nephrol; 2019 Mar; 34(3):379-388. PubMed ID: 29214442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.
    Zoja C; Buelli S; Morigi M
    Pediatr Nephrol; 2010 Nov; 25(11):2231-40. PubMed ID: 20424866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.